CA Stock MarketDetailed Quotes
PCRX PharmaCorp Rx Inc
- 0.670
- -0.030-4.29%
15min DelayMarket Closed Nov 4 16:00 ET
77.47MMarket Cap-25769P/E (TTM)
0.670High0.670Low8.09KVolume0.670Open0.700Pre Close5.43KTurnover0.87552wk High0.01%Turnover Ratio115.62MShares0.43052wk Low-0.026EPS TTM68.07MFloat Cap0.875Historical HighLossP/E (Static)101.60MShs Float0.430Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM3.45P/B1Lot Size--Div YieldTTM
PharmaCorp Rx Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 291.42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --291.42K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 192.75K | 0 | ||||||||
| Gross profit | 98.66K | 0 | ||||||||
| Operating expense | 637.71%703.65K | 104.23%226.09K | 2.62%577.96K | 903.03%242.35K | 6,369.36%129.53K | -78.90%95.38K | 24.23%110.7K | 563.18K | 24.16K | -117.13%-2.07K |
| Selling and administrative expenses | 614.20%681.22K | 104.23%226.09K | 2.62%577.96K | 903.03%242.35K | 6,369.36%129.53K | -78.90%95.38K | 24.23%110.7K | --563.18K | --24.16K | -117.13%-2.07K |
| -General and administrative expense | 614.20%681.22K | 104.23%226.09K | 2.62%577.96K | 903.03%242.35K | 6,369.36%129.53K | -78.90%95.38K | 24.23%110.7K | --563.18K | --24.16K | -117.13%-2.07K |
| Depreciation amortization depletion | --22.43K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | --22.43K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Operating profit | -534.27%-604.99K | -104.23%-226.09K | -2.62%-577.96K | -903.03%-242.35K | -6,369.36%-129.53K | 78.90%-95.38K | -24.23%-110.7K | -563.18K | -24.16K | 117.13%2.07K |
| Net non-operating interest income (expenses) | -59.42%10.66K | -10.66%23.62K | 133.30%107.53K | 21.24%26.16K | 54.75%28.66K | 402.87%26.28K | 3,333.38%26.44K | 46.09K | 21.58K | 1,852,000.00%18.52K |
| Non-operating interest income | -42.73%15.05K | -10.66%23.62K | 133.30%107.53K | 21.24%26.16K | 54.75%28.66K | 402.87%26.28K | 3,333.38%26.44K | --46.09K | --21.58K | 1,852,000.00%18.52K |
| Non-operating interest expense | --4.39K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | ||||||||||
| Income before tax | -759.99%-594.33K | -140.28%-202.47K | 9.02%-470.43K | -8,260.13%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | -517.09K | -2.59K | 270.66%20.59K |
| Income tax | -249 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -759.63%-594.08K | -140.28%-202.47K | 9.02%-470.43K | -8,260.13%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | -517.09K | -2.59K | 270.66%20.59K |
| Net income continuous operations | -759.63%-594.08K | -140.28%-202.47K | 9.02%-470.43K | -8,260.13%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | ---517.09K | ---2.59K | 270.66%20.59K |
| Noncontrolling interests | 1.67K | 0 | ||||||||
| Net income attributable to the company | -762.04%-595.74K | -140.28%-202.47K | 9.02%-470.43K | -8,256.90%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | -517.09K | -2.59K | 270.66%20.59K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -762.04%-595.74K | -140.28%-202.47K | 9.02%-470.43K | -8,256.90%-216.19K | -589.94%-100.86K | 84.53%-69.11K | 4.62%-84.26K | -517.09K | -2.59K | 270.66%20.59K |
| Diluted earnings per share | -482.41%-0.01 | -375.96%-0.01 | 50.00%-0.01 | 0 | -586.21%-0.0025 | 82.83%-0.0017 | 4.89%-0.0021 | -0.02 | 0 | 270.53%0.0005 |
| Basic earnings per share | -482.41%-0.01 | -375.96%-0.01 | 50.00%-0.01 | 0 | -586.21%-0.0025 | 82.83%-0.0017 | 4.89%-0.0021 | -0.02 | 0 | 270.53%0.0005 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data